Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 122


Matrix metalloproteinase 9 modulates collagen matrices and wound repair.

LeBert DC, Squirrell JM, Rindy J, Broadbridge E, Lui Y, Zakrzewska A, Eliceiri KW, Meijer AH, Huttenlocher A.

Development. 2015 Jun 15;142(12):2136-46. doi: 10.1242/dev.121160. Epub 2015 May 26.


Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression.

Voll EA, Ogden IM, Pavese JM, Huang X, Xu L, Jovanovic BD, Bergan RC.

Oncotarget. 2014 May 15;5(9):2648-63.


Can effluent matrix metalloproteinase 2 and plasminogen activator inhibitor 1 be used as biomarkers of peritoneal membrane alterations in peritoneal dialysis patients?

Barreto DL, Coester AM, Struijk DG, Krediet RT.

Perit Dial Int. 2013 Sep-Oct;33(5):529-37. doi: 10.3747/pdi.2012.01063. Epub 2013 Sep 1.


Bisphenol A stimulates human prostate cancer cell migration via remodelling of calcium signalling.

Derouiche S, Warnier M, Mariot P, Gosset P, Mauroy B, Bonnal JL, Slomianny C, Delcourt P, Prevarskaya N, Roudbaraki M.

Springerplus. 2013 Dec;2(1):54. doi: 10.1186/2193-1801-2-54. Epub 2013 Feb 15.


Molecular design of a highly selective and strong protein inhibitor against matrix metalloproteinase-2 (MMP-2).

Higashi S, Hirose T, Takeuchi T, Miyazaki K.

J Biol Chem. 2013 Mar 29;288(13):9066-76. doi: 10.1074/jbc.M112.441758. Epub 2013 Feb 10.


Fibroblast growth factor receptor 1 activation in mammary tumor cells promotes macrophage recruitment in a CX3CL1-dependent manner.

Reed JR, Stone MD, Beadnell TC, Ryu Y, Griffin TJ, Schwertfeger KL.

PLoS One. 2012;7(9):e45877. doi: 10.1371/journal.pone.0045877. Epub 2012 Sep 24.


The history of matrix metalloproteinases: milestones, myths, and misperceptions.

Iyer RP, Patterson NL, Fields GB, Lindsey ML.

Am J Physiol Heart Circ Physiol. 2012 Oct 15;303(8):H919-30. doi: 10.1152/ajpheart.00577.2012. Epub 2012 Aug 17. Review.


Chronic treatment with a broad-spectrum metalloproteinase inhibitor, doxycycline, prevents the development of spontaneous aortic lesions in a mouse model of vascular Ehlers-Danlos syndrome.

Tae HJ, Marshall S, Zhang J, Wang M, Briest W, Talan MI.

J Pharmacol Exp Ther. 2012 Oct;343(1):246-51. doi: 10.1124/jpet.112.197020. Epub 2012 Jul 19.


Fine-structural distribution of MMP-2 and MMP-9 activities in the rat skeletal muscle upon training: a study by high-resolution in situ zymography.

Yeghiazaryan M, Żybura-Broda K, Cabaj A, Włodarczyk J, Sławińska U, Rylski M, Wilczyński GM.

Histochem Cell Biol. 2012 Jul;138(1):75-87. doi: 10.1007/s00418-012-0940-5. Epub 2012 Mar 15.


Diffusion of MMPs on the surface of collagen fibrils: the mobile cell surface-collagen substratum interface.

Collier IE, Legant W, Marmer B, Lubman O, Saffarian S, Wakatsuki T, Elson E, Goldberg GI.

PLoS One. 2011;6(9):e24029. doi: 10.1371/journal.pone.0024029. Epub 2011 Sep 1.


Elevation of hemopexin-like fragment of matrix metalloproteinase-2 tissue levels inhibits ischemic wound healing and angiogenesis.

Nedeau AE, Gallagher KA, Liu ZJ, Velazquez OC.

J Vasc Surg. 2011 Nov;54(5):1430-8. doi: 10.1016/j.jvs.2011.05.029. Epub 2011 Sep 8.


Peptide from the C-terminal domain of tissue inhibitor of matrix metalloproteinases-2 (TIMP-2) inhibits membrane activation of matrix metalloproteinase-2 (MMP-2).

Xu X, Mikhailova M, Chen Z, Pal S, Robichaud TK, Lafer EM, Baber S, Steffensen B.

Matrix Biol. 2011 Sep;30(7-8):404-12. doi: 10.1016/j.matbio.2011.07.001. Epub 2011 Aug 4.


Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency.

Omachi TA, Eisner MD, Rames A, Markovtsova L, Blanc PD.

Respir Res. 2011 Mar 23;12:35. doi: 10.1186/1465-9921-12-35.


Assessment of Gelatinases (MMP-2 and MMP-9 by Gelatin Zymography.

Toth M, Fridman R.

Methods Mol Med. 2001;57:163-74. doi: 10.1385/1-59259-136-1:163.


Fragmentation of fibronectin by inherent autolytic and matrix metalloproteinase activities.

Steffensen B, Chen Z, Pal S, Mikhailova M, Su J, Wang Y, Xu X.

Matrix Biol. 2011 Jan;30(1):34-42. doi: 10.1016/j.matbio.2010.09.004. Epub 2010 Oct 13.


Inhibition of cancer cell invasion and metastasis by genistein.

Pavese JM, Farmer RL, Bergan RC.

Cancer Metastasis Rev. 2010 Sep;29(3):465-82. doi: 10.1007/s10555-010-9238-z. Review.


Matrix metalloproteinase 9 plays a key role in lyme arthritis but not in dissemination of Borrelia burgdorferi.

Heilpern AJ, Wertheim W, He J, Perides G, Bronson RT, Hu LT.

Infect Immun. 2009 Jul;77(7):2643-9. doi: 10.1128/IAI.00214-09. Epub 2009 Apr 13.


Enhanced angiogenesis and reduced contraction in thrombospondin-2-null wounds is associated with increased levels of matrix metalloproteinases-2 and -9, and soluble VEGF.

Maclauchlan S, Skokos EA, Agah A, Zeng J, Tian W, Davidson JM, Bornstein P, Kyriakides TR.

J Histochem Cytochem. 2009 Apr;57(4):301-13. doi: 10.1369/jhc.2008.952689. Epub 2008 Nov 24.


The arthritis severity locus Cia5d is a novel genetic regulator of the invasive properties of synovial fibroblasts.

Laragione T, Brenner M, Mello A, Symons M, Gulko PS.

Arthritis Rheum. 2008 Aug;58(8):2296-306. doi: 10.1002/art.23610.


Malignant Fibrous Histiocytoma, Aggressive Fibromatosis and Benign Fibrous Tumors Express mRNA for the Metalloproteinase Inducer EMMPRIN and the Metalloproteinases MMP-2 and MT1-MMP.

Ahlén J, Enberg U, Larsson C, Larsson O, Frisk T, Brosjö O, Rosen A, Bäckdahl M.

Sarcoma. 2001;5(3):143-9. doi: 10.1080/13577140120048601.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk